Insider10% Owner
Omega Fund V, L.P. Insider Trading Activity
Every SEC Form 4 transaction reported by Omega Fund V, L.P., sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Is Omega Fund V, L.P. buying or selling?
Omega Fund V, L.P. reported 3 open-market buys ($15.4M) and 49 sells ($116.3M) across 52 Form 4 filings at 5 companies — a net selling position of $100.9M.
Source: SEC EDGAR Form 4
Key Statistics (as of Apr 7, 2022)
Total Form 4 filings
52
SEC EDGAR
Companies
5
Buys (3)
$15.4M
Sells (49)
$116.3M
Insider sentiment
Net sellingNet insider flow of $100.9M in net selling, filed between May 13, 2019 – Apr 7, 2022.
Companies Omega Fund V, L.P. files for
Recent Omega Fund V, L.P. transactions
| Date | Ticker | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Apr 7, 2022 | NUVB | 10% Owner | Sale | 2.5M | $14.0M |
| Dec 17, 2021 | NUVB | 10% Owner | Sale | 500.0K | $5.0M |
| Dec 9, 2021 | NUVB | 10% Owner | Sale | 1.4M | $13.7M |
| Nov 24, 2021 | NUVB | 10% Owner | Sale | 295.0K | $2.9M |
| Nov 5, 2021 | NUVB | 10% Owner | Sale | 2.0M | $18.5M |
| Nov 1, 2021 | NUVB | 10% Owner | Sale | 1.1M | $10.2M |
| May 3, 2021 | MORF | Director | Sale | 17.2K | $937.7K |
| Apr 29, 2021 | MORF | Director | Sale | 10.7K | $593.3K |
| Apr 27, 2021 | MORF | Director | Sale | 13.8K | $773.8K |
| Apr 23, 2021 | MORF | Director | Sale | 19.8K | $1.1M |
| Apr 21, 2021 | MORF | Director | Sale | 17.9K | $970.5K |
| Apr 19, 2021 | MORF | Director | Sale | 17.7K | $987.1K |
| Apr 15, 2021 | MORF | Director | Sale | 20.9K | $1.2M |
| Apr 13, 2021 | MORF | Director | Sale | 24.8K | $1.4M |
| Apr 9, 2021 | MORF | Director | Sale | 26.7K | $1.6M |
| Apr 7, 2021 | MORF | Director | Sale | 20.4K | $1.3M |
| Apr 2, 2021 | MORF | Director | Sale | 30.4K | $1.9M |
| Mar 31, 2021 | MORF | Director | Sale | 36.1K | $2.2M |
| Mar 29, 2021 | MORF | Director | Sale | 47.9K | $2.8M |
| Mar 25, 2021 | MORF | Director | Sale | 52.3K | $3.2M |
| Mar 23, 2021 | MORF | Director | Sale | 25.8K | $1.6M |
| Mar 19, 2021 | MORF | Director | Sale | 35.9K | $2.3M |
| Mar 17, 2021 | MORF | Director | Sale | 64.4K | $4.2M |
| Mar 1, 2021 | MORF | Director | Sale | 36.0K | $1.3M |
| Feb 25, 2021 | MORF | Director | Sale | 10.5K | $360.3K |
Showing the 25 most recent filings of 52. Screen every filing.
Omega Fund V, L.P. insider trading FAQ
Is Omega Fund V, L.P. buying or selling?
Across 52 SEC Form 4 filings, Omega Fund V, L.P. reported 3 open-market purchases totaling $15.4M and 49 sales totaling $116.3M — a net selling position of $100.9M.
Which companies does Omega Fund V, L.P. file Form 4s for?
Omega Fund V, L.P. has reported insider transactions at 5 companies, most often Morphic Holding, Inc. (MORF), Nuvation Bio Inc. (NUVB), Gossamer Bio, Inc. (GOSS), Kronos Bio, Inc. (KRON), Trevi Therapeutics, Inc. (TRVI).
How far back does Omega Fund V, L.P.'s filing history go?
Trabud holds Omega Fund V, L.P.'s SEC Form 4 filings from May 13, 2019 – Apr 7, 2022, sourced directly from SEC EDGAR.
Where does Trabud get Omega Fund V, L.P.'s insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Omega Fund V, L.P. and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener